W. Oosterlinck Et Al. , "Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guerin and with Bacillus Calmette-Guerin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)," EUROPEAN UROLOGY , vol.59, no.3, pp.438-446, 2011
Oosterlinck, W. Et Al. 2011. Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guerin and with Bacillus Calmette-Guerin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993). EUROPEAN UROLOGY , vol.59, no.3 , 438-446.
Oosterlinck, W., Kirkali, Z., Sylvester, R., da Silva, F. C., Busch, C., Algaba, F., ... Collette, S.(2011). Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guerin and with Bacillus Calmette-Guerin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993). EUROPEAN UROLOGY , vol.59, no.3, 438-446.
Oosterlinck, Willem Et Al. "Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guerin and with Bacillus Calmette-Guerin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)," EUROPEAN UROLOGY , vol.59, no.3, 438-446, 2011
Oosterlinck, Willem Et Al. "Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guerin and with Bacillus Calmette-Guerin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)." EUROPEAN UROLOGY , vol.59, no.3, pp.438-446, 2011
Oosterlinck, W. Et Al. (2011) . "Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guerin and with Bacillus Calmette-Guerin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)." EUROPEAN UROLOGY , vol.59, no.3, pp.438-446.
@article{article, author={Willem Oosterlinck Et Al. }, title={Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guerin and with Bacillus Calmette-Guerin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)}, journal={EUROPEAN UROLOGY}, year=2011, pages={438-446} }